Exploring the link between type 2 diabetes medications and reduced cancer risk
Recent studies have shed light on the potential benefits of certain type 2 diabetes medications beyond glucose control. Notably, medications classified as glucagon-like peptide receptor agonists (GLP-1RAs), such as Ozempic, have been linked to a reduced risk of several obesity-related cancers. Key findings from recent research A study published in JAMA Network Open highlights that […]